Bellerophon Therapeutics, Inc. Marketable Securities
Bellerophon Therapeutics, Inc. had Marketable Securities of $0 as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2019-03-14
- 2018-12-31: Marketable Securities $0.00.
- 2018-09-30: Marketable Securities $998.00K.
- 2018-06-30: Marketable Securities $2.50M.
- 2018-03-31: Marketable Securities $2.99M.
| Period end | Marketable Securities |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2018-09-30 | $998.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.50M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $2.99M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.00M 10-K · filed 2019-03-14 |
| 2017-09-30 | $3.18M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.90M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $3.11M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $5.57M 10-K · filed 2018-03-15 |
| 2016-09-30 | $7.23M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $11.92M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $16.09M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $17.81M 10-K · filed 2017-03-13 |
| 2015-09-30 | $17.39M 10-Q · filed 2015-11-12 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-21 |